SRXH ▼ -0.6% - SRX Global Inc. $SRXH - SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers SRX Global announced it has acquired senior secured debt in CERo Therapeutics Holdings, a cellular immunotherapy company developing treatments for hematologic cancers. Despite the company's expansion into a promising therapeutic area, shares declined 0.6% today, suggesting investors may have concerns about the terms of the debt acquisition, the capital required, or questions about CERo's development timeline and commercial prospects. 31-AUG-2026 07:30 AM ET